Identification and Prediction of Diabetic Sensorimotor Polyneuropathy Using Individual and Simple Combinations of Nerve Conduction Study Parameters

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Weisman, Alanna ^a   Bril, Vera ^a   Ngo, Mylan ^a   Lovblom, Leif E ^a   Halpern, Elise M ^a   Orszag, Andrej ^a   Perkins, Bruce A ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CONCURRENT VALIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC NEUROPATHY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; FEMALE; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERONEAL AMPLITUDE POTENTIAL; PERONEAL CONDUCTION VELOCITY; PERONEAL F WAVE LATENCY; PREDICTIVE VALIDITY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SENSORIMOTOR NEUROPATHY; SENSORY NERVE CONDUCTION; SENSORY SYSTEM PARAMETERS; SURAL AMPLITUDE POTENTIAL; SURAL CONDUCTION VELOCITY; TIBIAL AMPLITUDE POTENTIAL; TIBIAL CONDUCTION VELOCITY; TIBIAL F WAVE LATENCY;

AGED; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURAL CONDUCTION;

EID: 84875307018     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058783     Document Type: Article

References (40)

1. Dyck PJ, Overland CJ, Low PA, Litchy WJ, Davies JL, et al. (2010) Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys trial. Muscle Nerve 42: 157-164.
2. Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, et al. (1993) The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 43: 817-824.
3. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, et al. (2005) Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 28: 956-962.
4. Hsu WC, Chiu SY, Yen AM, Chen LS, Fann CY, et al. (2012) Somatic neuropathy is an independent predictor of all- and diabetes-related mortality in type 2 diabetic patients: a population-based 5-year follow-up study (KCIS No. 29). Eur J Neurol.
5. Forsblom CM, Sane T, Groop PH, Totterman KJ, Kallio M, et al. (1998) Risk factors for mortality in Type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4. Diabetologia 41: 1253-1262.
6. Carrington AL, Shaw JE, Van Schie CH, Abbott CA, Vileikyte L, et al. (2002) Can motor nerve conduction velocity predict foot problems in diabetic subjects over a 6-year outcome period? Diabetes Care 25: 2010-2015.
7. Soedamah-Muthu S, Chaturvedi N, Witte D, Stevens L, Porta M, et al. (2008) Relationship between risk factors and mortality in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study (PCS). Diabetes Care 31: 1360-1366.
8. Pop-Busui R, Herman WH, Feldman EL, Low PA, Martin CL, et al. (2010) DCCT and EDIC studies in type 1 diabetes: lessons for diabetic neuropathy regarding metabolic memory and natural history. Curr Diab Rep 10: 276-282.
9. Tesfaye S, Chaturvedi N, Eaton SE, Ward JD, Manes C, et al. (2005) Vascular risk factors and diabetic neuropathy. N Engl J Med 352: 341-350.
10. Albers JW, Herman WH, Pop-Busui R, Feldman EL, Martin CL, et al. (2010) Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study. Diabetes Care 33: 1090-1096.
11. England JD, Gronseth GS, Franklin G, Miller RG, Asbury AK, et al. (2005) Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 64: 199-207.
12. Dyck PJ, Albers JW, Andersen H, Arezzo JC, Biessels GJ, et al. (2011) Diabetic Polyneuropathies: Update on Research Definition, Diagnostic Criteria and Estimation of Severity. Diabetes Metab Res Rev.
13. Zinman LH, Bril V, Perkins BA, (2004) Cooling detection thresholds in the assessment of diabetic sensory polyneuropathy: comparison of CASE IV and Medoc instruments. Diabetes Care 27: 1674-1679.
14. Dyck PJ, Karnes JL, O'Brien PC, Litchy WJ, Low PA, et al. (1992) The Rochester Diabetic Neuropathy Study: reassessment of tests and criteria for diagnosis and staged severity. Neurology 42: 1164-1170.
15. Perkins BA, Orszag A, Ngo M, Ng E, New P, et al. (2010) Prediction of incident diabetic neuropathy using the monofilament examination: a 4-year prospective study. Diabetes Care 33: 1549-1554.
16. Bril V, (1999) NIS-LL: the primary measurement scale for clinical trial endpoints in diabetic peripheral neuropathy. Eur Neurol 41Suppl 1: 8-13.
17. Bril V, Tomioka S, Buchanan RA, Perkins BA, (2009) Reliability and validity of the modified Toronto Clinical Neuropathy Score in diabetic sensorimotor polyneuropathy. Diabet Med 26: 240-246.
18. Mythili A, Kumar KD, Subrahmanyam KA, Venkateswarlu K, Butchi RG, (2010) A Comparative study of examination scores and quantitative sensory testing in diagnosis of diabetic polyneuropathy. Int J Diabetes Dev Ctries 30: 43-48.
19. Martin CL, Waberski BH, Pop-Busui R, Cleary PA, Catton S, et al. (2010) Vibration perception threshold as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the DCCT/EDIC study. Diabetes Care 33: 2635-2641.
20. Bril V, Perkins BA, (2002) Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy. Diabetes Care 25: 2048-2052.
21. Perkins BA, Olaleye D, Zinman B, Bril V, (2001) Simple screening tests for peripheral neuropathy in the diabetes clinic. Diabetes Care 24: 250-256.
22. Orszag A, Shin T, Bril V, Perkins BA, (2011) Dorsal versus ventral monofilament testing of the great toe for the identification of diabetic sensorimotor polyneuropathy. Diabetes Research and Clinical Pactice 93: e71-e73.
23. Oh S (2002) Normal values for common nerve conduction tests. Baltimore: Lippincott Williams & Wilkins.
24. (1999) Guidelines in electrodiagnostic medicine. Recommended policy for electrodiagnostic medicine. Muscle Nerve Suppl 8: S91-105.
25. Bolton CF, Benstead TJ, Grand'Maison F, Tardif GS, Weston LE, (2000) Minimum standards for electromyography in Canada: a statement of the Canadian Society of Clinical Neurophysiologists. Can J Neurol Sci 27: 288-291.
26. Bril V, Hirose T, Tomioka S, Buchanan R, (2009) Ranirestat for the management of diabetic sensorimotor polyneuropathy. Diabetes Care 32: 1256-1260.
27. Hanley JA, McNeil BJ, (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143: 29-36.
28. Lasko T, Bhagwat J, Zou K, Ohno-Machado L, (2005) The use of receiver operating characteristic curves in biomedical informatics. Journal of Biomedical Informatics 38: 404-415.
29. Pencina MJ, D'Agostino RB, Sr., D'Agostino RB, Jr., Vasan RS (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27: 157-172; discussion 207-112.
30. Harris S, Woall G, Macaulay A, Norton P, Webster-Bogaert S, et al. (2006) Diabetes Management in Canada: baseline results of the group practice diabetes management study. Canadian Journal of Diabetes 30: 131-137.
31. Callaghan BC, Feldman E, Liu J, Kerber K, Pop-Busui R,et al. Triglycerides and amputation risk in patients with diabetes: ten-year follow-up in the DISTANCE study. Diabetes Care 34: 635-640.
32. Charles M, Soedamah-Muthu SS, Tesfaye S, Fuller JH, Arezzo JC,et al. Low peripheral nerve conduction velocities and amplitudes are strongly related to diabetic microvascular complications in type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetes Care 33: 2648-2653.
33. Dyck PJ, Carter RE, Litchy WJ, (2011) Modeling nerve conduction criteria for diagnosis of diabetic polyneuropathy. Muscle Nerve 44: 340-345.
34. Dyck PJ, Litchy WJ, Daube JR, Harper CM, Davies J, et al. (2003) Individual attributes versus composite scores of nerve conduction abnormality: sensitivity, reproducibility, and concordance with impairment. Muscle Nerve 27: 202-210.
35. Lamontagne A, Buchthal F, (1970) Electrophysiological studies in diabetic neuropathy. J Neurol Neurosurg Psychiatry 33: 442-452.
36. Behse F, Buchhal F, Carlsen F, (1977) Neve biopsy and conduction studies in diabetic neuropathy. J Neurol Neurosurg Psychiatry 40: 1072-1082.
37. Andersen H, Stalberg E, Falck B, (1997) F-wave latency, the most sensitive nerve conduction parameter in patients with diabetes mellitus. Muscle Nerve 20: 1296-1302.
38. Kohara N, Kimura J, Kaji R, Goto Y, Ishii J, et al. (2000) F-wave latency serves as the most reproducible measure in nerve conduction studies of diabetic polyneuropathy: multicentre analysis in healthy subjects and patients with diabetic polyneuropathy. Diabetologia 43: 915-921.
39. Karsidag S, Morali S, Sargin M, Salman S, Karsidag K, et al. (2005) The electrophysiological findings of subclinical neuropathy in patients with recently diagnosed type 1 diabetes mellitus. Diabetes Res Clin Pract 67: 211-219.
40. Gentile S, Turco S, Corigliano G, Marmo R, (1995) Simplified diagnostic criteria for diabetic distal polyneuropathy. Preliminary data of a multicentre study in the Campania region. S.I.M.S.D.N. Group. Acta Diabetol 32: 7-12.